ni2o
ni2o is a neuroscience company focused on developing revolutionary brain-computer interface (BCI) technology to address neurodegenerative diseases. Spinout of Oxford University, ni2o aims to restore human dignity by creating minimally invasive, technologically advanced treatments for brain disorders, starting with Parkinson's and Alzheimer’s diseases. The company leverages neuroscience principles, AI, and innovative implantable systems like KIWI to improve patient outcomes and reduce treatment costs.
Industries
Nr. of Employees
small (1-50)
Products
Minimally invasive wireless neural implant for deep brain stimulation
A small, self‑contained implantable device designed to record neural activity and deliver electrical and optical stimulation. Device is intended to be wirelessly charged and wirelessly connected to a cloud analytics platform for adaptive therapy control.
Minimally invasive wireless neural implant for deep brain stimulation
A small, self‑contained implantable device designed to record neural activity and deliver electrical and optical stimulation. Device is intended to be wirelessly charged and wirelessly connected to a cloud analytics platform for adaptive therapy control.
Services
Design and R&D services for implantable neuromodulation devices, including device architecture, surgical implantation approach development, and preclinical evaluation of recording/stimulation capabilities.
Research and development of neuromorphic architectures that combine analog and digital processing units to improve energy efficiency, latency, and throughput for brain‑inspired computing applications.
Comparative assessment and consulting on implant powering strategies (electromagnetic, acoustic, optical, direct), including evaluation of energy transfer efficiency and biocompatibility implications.
Development of cloud platform capabilities for secure neural data capture, real‑time interpretation, and continuous improvement of therapeutic algorithms via machine learning.
Design and R&D services for implantable neuromodulation devices, including device architecture, surgical implantation approach development, and preclinical evaluation of recording/stimulation capabilities.
Research and development of neuromorphic architectures that combine analog and digital processing units to improve energy efficiency, latency, and throughput for brain‑inspired computing applications.
Comparative assessment and consulting on implant powering strategies (electromagnetic, acoustic, optical, direct), including evaluation of energy transfer efficiency and biocompatibility implications.
Development of cloud platform capabilities for secure neural data capture, real‑time interpretation, and continuous improvement of therapeutic algorithms via machine learning.
Expertise Areas
- Brain‑computer interfaces
- Closed‑loop neuromodulation
- Neuromorphic computing and mixed‑signal design
- Wireless power and telemetry for implantables
Key Technologies
- Brain‑computer interface (BCI) systems
- Closed‑loop electrical stimulation
- Optical neural stimulation
- Wireless power transfer (RF, ultrasound, optical)
News & Updates
Explore ni2o’s new publication on the Brain Code Unit (BCU) and Fundamental Code Unit (FCU), integrating neuroscience principles with computational design techniques. The work demonstrates significant improvements in latency and throughput for neuromorphic systems.
ni2o reviews various energy transfer methods for neural implants, including electromagnetic, acoustic, optical, and direct connection, focusing on biocompatibility and long-term safety, with a special emphasis on their own KIWI device.
Dr. Howard presents ni2o’s mission to eradicate neurodegenerative diseases at Dubai’s AI Summit in 2021, highlighting the company’s innovative approach and global engagement.
ni2o was recognized as a top tech startup in Providence, RI, with Dr. Howard featured as the founder overcoming challenges to achieve this accolade.
Scientists have created a BCI that translates thoughts into sound, allowing for applications in entertainment, social cohesion, and medical therapy.
Brain computer interfaces (BCI) can translate thoughts into actions using AI. Researchers have used deepfake technology to speed up BCI training by up to 20 times, enabling applications like wheelchair control and mental health treatment.
Explore ni2o’s new publication on the Brain Code Unit (BCU) and Fundamental Code Unit (FCU), integrating neuroscience principles with computational design techniques. The work demonstrates significant improvements in latency and throughput for neuromorphic systems.
ni2o reviews various energy transfer methods for neural implants, including electromagnetic, acoustic, optical, and direct connection, focusing on biocompatibility and long-term safety, with a special emphasis on their own KIWI device.
Dr. Howard presents ni2o’s mission to eradicate neurodegenerative diseases at Dubai’s AI Summit in 2021, highlighting the company’s innovative approach and global engagement.
ni2o was recognized as a top tech startup in Providence, RI, with Dr. Howard featured as the founder overcoming challenges to achieve this accolade.
Scientists have created a BCI that translates thoughts into sound, allowing for applications in entertainment, social cohesion, and medical therapy.
Brain computer interfaces (BCI) can translate thoughts into actions using AI. Researchers have used deepfake technology to speed up BCI training by up to 20 times, enabling applications like wheelchair control and mental health treatment.